Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dean Scholl

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Journal of Bacteriology|July 27, 2016
F-Type Bacteriocins of Listeria monocytogenes: a New Class of Phage Tail-Like Structures Reveals Broad Parallel Coevolution between Tailed Bacteriophages and High-Molecular-Weight BacteriocinsGrace Lee, Urmi Chakraborty, Dana Gebhart, et al.
Nature Structural & Molecular Biology|March 31, 2015
Atomic structures of a bactericidal contractile nanotube in its pre- and postcontraction statesPeng Ge, Dean Scholl, Petr G Leiman, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2009
An engineered R-type pyocin is a highly specific and sensitive bactericidal agent for the food-borne pathogen Escherichia coli O157:H7Dean Scholl, Mike Cooley, Steve R Williams, et al.
Nature Communications|August 16, 2024
Atomic structures of a bacteriocin targeting Gram-positive bacteriaXiaoying Cai, Yao He, Iris Yu, et al.
Research Square|April 8, 2024
Atomic structures of a bacteriocin targeting Gram-positive bacteriaXiaoying Cai, Yao He, Iris Yu, et al.
Canadian Journal of Microbiology|August 26, 2021
Recombinant R2-pyocin cream is effective in treating <i>Pseudomonas aeruginosa-</i>infected woundsAbdulaziz Alqahtani, London Mena, Dean Scholl, et al.
Science Translational Medicine|September 8, 2017
New class of precision antimicrobials redefines role of <i>Clostridium difficile</i> S-layer in virulence and viabilityJoseph A Kirk, Dana Gebhart, Anthony M Buckley, et al.
Mbio|March 26, 2015
A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversityDana Gebhart, Stephen Lok, Simon Clare, et al.
Journal of Molecular Biology|June 26, 2007
The structures of bacteriophages K1E and K1-5 explain processive degradation of polysaccharide capsules and evolution of new host specificitiesPetr G Leiman, Anthony J Battisti, Valorie D Bowman, et al.
Antimicrobial Agents and Chemotherapy|September 28, 2011
An Escherichia coli O157-specific engineered pyocin prevents and ameliorates infection by E. coli O157:H7 in an animal model of diarrheal diseaseJennifer M Ritchie, Jennifer L Greenwich, Brigid M Davis, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Bacteriology|July 27, 2016
F-Type Bacteriocins of Listeria monocytogenes: a New Class of Phage Tail-Like Structures Reveals Broad Parallel Coevolution between Tailed Bacteriophages and High-Molecular-Weight BacteriocinsGrace Lee, Urmi Chakraborty, Dana Gebhart, et al.
Nature Structural & Molecular Biology|March 31, 2015
Atomic structures of a bactericidal contractile nanotube in its pre- and postcontraction statesPeng Ge, Dean Scholl, Petr G Leiman, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2009
An engineered R-type pyocin is a highly specific and sensitive bactericidal agent for the food-borne pathogen Escherichia coli O157:H7Dean Scholl, Mike Cooley, Steve R Williams, et al.
Nature Communications|August 16, 2024
Atomic structures of a bacteriocin targeting Gram-positive bacteriaXiaoying Cai, Yao He, Iris Yu, et al.
Research Square|April 8, 2024
Atomic structures of a bacteriocin targeting Gram-positive bacteriaXiaoying Cai, Yao He, Iris Yu, et al.
Canadian Journal of Microbiology|August 26, 2021
Recombinant R2-pyocin cream is effective in treating <i>Pseudomonas aeruginosa-</i>infected woundsAbdulaziz Alqahtani, London Mena, Dean Scholl, et al.
Science Translational Medicine|September 8, 2017
New class of precision antimicrobials redefines role of <i>Clostridium difficile</i> S-layer in virulence and viabilityJoseph A Kirk, Dana Gebhart, Anthony M Buckley, et al.
Mbio|March 26, 2015
A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversityDana Gebhart, Stephen Lok, Simon Clare, et al.
Journal of Molecular Biology|June 26, 2007
The structures of bacteriophages K1E and K1-5 explain processive degradation of polysaccharide capsules and evolution of new host specificitiesPetr G Leiman, Anthony J Battisti, Valorie D Bowman, et al.
Antimicrobial Agents and Chemotherapy|September 28, 2011
An Escherichia coli O157-specific engineered pyocin prevents and ameliorates infection by E. coli O157:H7 in an animal model of diarrheal diseaseJennifer M Ritchie, Jennifer L Greenwich, Brigid M Davis, et al.
Pageof 3